Anna U. Loengard - 14 Mar 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Director
Signature: /s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard
Issuer symbol: CLOV
Transactions as of: 14 Mar 2024
Net transactions value: +$109,956
Form type: 4
Filing time: 18 Mar 2024, 16:30:53 UTC
Previous filing: 05 Jan 2024
Next filing: 20 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Purchase	$100,010	+137,000	+34%	$0.7300	538,841	14 Mar 2024	Direct	F1
transaction	CLOV	Class A Common Stock	Purchase	$9,946	+13,625	+908%	$0.7300	15,125	14 Mar 2024	By Daughter in a Custodial Account
holding	CLOV	Class A Common Stock						10,000	14 Mar 2024	By Spouse IRA
holding	CLOV	Class A Common Stock						1,300	14 Mar 2024	By Son in a Custodial Account

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.